Eric Elias
About Eric Elias
Eric Elias is a Haematology Medical Science Liaison at Bristol Myers Squibb in Sydney, Australia, with over 20 years of experience in the pharmaceutical and healthcare industries.
Title
Eric Elias holds the position of Haematology Medical Science Liaison at Bristol Myers Squibb. In this role, he operates out of Sydney, New South Wales, Australia, contributing his extensive expertise in the field of hematology.
Employment History at Celgene
Eric Elias worked at Celgene in various capacities over a span of 9 years. From 2019 to 2020, he served as a Key Account Manager, managing critical accounts in Sydney, Australia. Prior to this role, he was a Senior Haematology/Oncology Specialist Representative from 2012 to 2020, specializing in haematology and oncology.
Experience in Pharmaceutical Industry
With over 20 years of experience, Eric Elias has a robust background in the pharmaceutical and healthcare industries. His career began at Amersham Australia as a Life Sciences Product Specialist. He has worked for major pharmaceutical companies, including Schering-Plough, CSL Bioplasma Ltd., and Celgene, holding various specialist and liaison roles.
Previous Roles in Healthcare
Prior to his current role, Eric Elias held several positions that shaped his professional journey. He was a Product Liaison Specialist at CSL Bioplasma Ltd. (2008-2012), a Gastroenterology Product Specialist at Colocap Pharmaceuticals (2007-2008), and a Hepatology & Infectious Diseases Specialist Representative at Schering-Plough (2003-2007). These roles have collectively bolstered his expertise in healthcare services.
Education and Expertise
Eric Elias studied at the University of the Witwatersrand, where he achieved a Master of Science degree in Medicine. He also attended King Edward VII School. His education laid the foundation for his extensive expertise in hematology, account management, and biotechnology.